International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

G Cammarota, G Ianiro, CR Kelly, BH Mullish… - Gut, 2019 - gut.bmj.com
Although faecal microbiota transplantation (FMT) has a well-established role in the treatment
of recurrent Clostridioides difficile infection (CDI), its widespread dissemination is limited by …

Fecal microbiota transplantation (FMT) with colonoscopy is superior to enema and nasogastric tube while comparable to capsule for the treatment of recurrent …

D Ramai, K Zakhia, PJ Fields, A Ofosu, G Patel… - Digestive diseases and …, 2021 - Springer
Background Several routes of fecal microbiota transplantation (FMT) administration are
available for treating recurrent Clostridioides difficile infections (CDI), the most recent of …

Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides difficile …

T Lodise, A Guo, M Yang, EE Cook, W Song… - Advances in …, 2023 - Springer
Abstract Introduction Recurrent Clostridioides difficile infection (rCDI) is common and
associated with considerable clinical and economic consequences. REBYOTA™(fecal …

Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines

R Rajasingham, EA Enns, A Khoruts… - Clinical infectious …, 2020 - academic.oup.com
Abstract Background In 2018, the Infectious Diseases Society of America (IDSA) published
guidelines for diagnosis and treatment of Clostridioides (formerly Clostridium) difficile …

[HTML][HTML] Evolution of fecal microbiota transplantation in methodology and ethical issues

F Zhang, T Zhang, H Zhu, TJ Borody - Current opinion in pharmacology, 2019 - Elsevier
Fecal microbiota transplantation (FMT), the core therapy for remodeling the gut microbiota
with a long medical history, has gained great attention worldwide in recent years. Increasing …

[HTML][HTML] Fidaxomicin vs vancomycin for the treatment of a first episode of Clostridium difficile infection: a meta-analysis and systematic review

LA Al Momani, O Abughanimeh, B Boonpheng… - Cureus, 2018 - ncbi.nlm.nih.gov
Clostridium difficile infection (CDI) continues to possess a significant disease burden in the
United States (US) as well as all over the world. Given the increase in severity and …

Cost-effectiveness of herpes zoster vaccination: a systematic review

ET Chiyaka, VT Nghiem, L Zhang, A Deshpande… - …, 2019 - Springer
Background Herpes zoster (HZ) is one of the most common diseases among adults. Its
reactivation is characterized by a severe and painful complication. In addition to the existing …

Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis

C Chen, L Chen, D Sun, C Li, S Xi, S Ding, R Luo… - Gut Pathogens, 2022 - Springer
Background Intestinal microbiota transplantation (IMT) has been recognized as an effective
treatment for recurrent Clostridium difficile infection (rCDI) and a novel treatment option for …

Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic …

LH Hammeken, SMD Baunwall, CL Hvas… - Health Economics …, 2021 - Springer
Background Faecal microbiota transplantation (FMT) is increasingly being used in the
treatment of recurrent Clostridioides difficile infection (rCDI). Health economic evaluations …

Health-related quality of life in patients with recurrent Clostridioides difficile infections

LH Hammeken, SMD Baunwall… - Therapeutic …, 2022 - journals.sagepub.com
Background: The health-related quality of life (HrQoL) can be substantially affected in
patients with recurrent Clostridioides difficile infection (rCDI) but the impact of effective …